Phase Holographic Imaging PHI AB (FRA:L5W) PEG Ratio: 0.00 (As of Jul. 12, 2026)


What is Phase Holographic Imaging PHI AB PEG Ratio?

Phase Holographic Imaging PHI AB FRA:L5W PEG Ratio is 0.00 as of Jul. 12, 2026. The stock has 5 warning signs investors should review.

PE Ratio without NRI / 5-Year EBITDA Growth Rate*

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The growth rate we use is the 5-Year EBITDA growth rate. As of today, Phase Holographic Imaging PHI AB's PE Ratio without NRI is 0.00. Phase Holographic Imaging PHI AB's 5-Year EBITDA growth rate is 25.50%. Therefore, Phase Holographic Imaging PHI AB's PEG Ratio for today is 0.00.

* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


The historical rank and industry rank for Phase Holographic Imaging PHI AB's PEG Ratio or its related term are showing as below:



FRA:L5W's PEG Ratio is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 1.93
* Ranked among companies with meaningful PEG Ratio only.

Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.


Phase Holographic Imaging PHI AB  (FRA:L5W) PEG Ratio Explanation

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.


Phase Holographic Imaging PHI AB PEG Ratio Related Terms


Phase Holographic Imaging PHI AB PEG Ratio Historical Data

* Premium members only.

The historical data trend for Phase Holographic Imaging PHI AB's PEG Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Phase Holographic Imaging PHI AB PEG Ratio Chart

Phase Holographic Imaging PHI AB Annual Data
Trend Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24 Apr25
PEG Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Phase Holographic Imaging PHI AB Quarterly Data
Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25
PEG Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

FRA:L5W vs ABT, BSX, SYK: PEG Ratio Comparison

For the Medical Devices subindustry, Phase Holographic Imaging PHI AB's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Phase Holographic Imaging PHI AB PEG Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Phase Holographic Imaging PHI AB's PEG Ratio distribution charts can be found below:

* The bar in red indicates where Phase Holographic Imaging PHI AB's PEG Ratio falls into.



Phase Holographic Imaging PHI AB PEG Ratio Calculation

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The ratio we use is the 5-Year EBITDA growth rate.

Phase Holographic Imaging PHI AB's PEG Ratio for today is calculated as

PEG Ratio=PE Ratio without NRI/5-Year EBITDA Growth Rate*
=/25.50
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.

Frequently Asked Questions Learn more about PEG Ratio →
What does a PEG Ratio of 0.00 mean?
Phase Holographic Imaging PHI AB (FRA:L5W) has a PEG Ratio of 0.00 as of Jul. 12, 2026. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Phase Holographic Imaging PHI AB and its competitors.
Is Phase Holographic Imaging PHI AB's PEG Ratio too high?
Phase Holographic Imaging PHI AB's current PEG Ratio is 0.00.
How does Phase Holographic Imaging PHI AB's PEG Ratio compare to ABT and BSX?
Phase Holographic Imaging PHI AB's PEG Ratio of 0.00 can be compared against companies in the Medical Devices & Instruments industry. The industry median PEG Ratio is 1.93. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PEG Ratio for a Medical Devices & Instruments company?
The median PEG Ratio among Medical Devices & Instruments companies is 1.93, based on 209 companies in the industry. Companies in the top quartile (top 25%) have a PEG Ratio significantly above this median, while those in the bottom quartile fall well below. However, PEG Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PEG Ratio mean?
A high PEG Ratio can signal that a stock is expensive relative to its fundamentals. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Phase Holographic Imaging PHI AB and its competitors. For the Medical Devices & Instruments industry, the median PEG Ratio is 1.93 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Phase Holographic Imaging PHI AB's current PEG Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Phase Holographic Imaging PHI AB stock overvalued right now?
Phase Holographic Imaging PHI AB (FRA:L5W) has a current PEG Ratio of 0.00. The stock's GF Value™ is €0.23, compared to a current price of €0.04 — trading 81% below its estimated fair value. The current PEG Ratio is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PEG Ratio calculated?
PEG Ratio is calculated from a company's financial statements. For Phase Holographic Imaging PHI AB (FRA:L5W), the current PEG Ratio is 0.00 as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Phase Holographic Imaging PHI AB Business Description

Address Skiffervagen 48, Lund, SWE, 224 78
Phase Holographic Imaging PHI AB is a medical device company that develops and markets non-invasive time-lapse imaging instruments used for the quantitative long-term analysis of living cell cultures. The company's commercial HoloMonitor products are based on Quantitative Phase Imaging (QPI) technology, which is used for real-time cell quality evaluation. Geographically, it has presence in Lund, Sweden, with offices in Boston, MA and Winston-Salem, NC.